Hong Liu,Xing Dai,Anandan Palani,Shuwen He,Ravi Nargund,Dong Xiao,Qun Dang,Xuanjia Peng,Peng Li
申请号：
US14898250
公开号：
US20160130259A1
申请日:
2014.06.19
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present invention relates to compounds of formula I that are useful as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system.
